Brainlab

Brainlab

Medical software and hardware for surgeries

Clinical Affairs Werkstudent Intern

InternshipPosted on 9/25/2026
No salary listed
Bachelor's
Munich, Germany
In Person

About the job

Requirements
  • Currently studying Marketing, Medical Technology, Business Administration, or a comparable field.
  • Very good verbal and written communication skills.
  • A careful, structured, and independent working style.
  • Good German and English skills, both spoken and written.
  • Availability for at least 24 months.
  • Availability to work 20 hours per week.
  • Strong interpersonal skills and the ability to work independently with a high sense of responsibility.
  • Good knowledge of Microsoft Office and strong organizational skills.
Responsibilities
  • Support the organization of usability tests for Brainlab products.
  • Maintain the database for clinical advisors and contracts in SharePoint and the customer relationship management system.
  • Support the contract negotiation process with clinical advisors.
  • Collaborate with the Brainlab legal department on contract negotiations, prepare required documents, and obtain signatures from the contracting parties.
  • Create and process New Supplier Requests for setting up new suppliers.
  • Compile billing documentation for clinical advisors.
  • Review and obtain approvals for invoices.
  • Communicate and coordinate with accounting and finance departments.
  • Maintain and continuously optimize the Clinical Affairs SharePoint page in close coordination with the Clinical Affairs team.
  • Contribute to optimizing existing processes.

About the company

Brainlab is a medical technology company that creates software and hardware to improve surgeries, radiosurgery treatments, and operating room efficiency. It serves hospitals and clinics by providing digital tools that enhance surgical precision and patient outcomes. The core products include image-guided navigation, planning software, and connected hardware that work together to guide procedures. Revenue comes from selling software licenses, hardware devices, and ongoing subscription services that include updates and support. The company differentiates itself by offering integrated digital medical technologies that combine software and hardware for a seamless clinical workflow, backed by service agreements. Its goal is to help healthcare providers perform safer, more accurate procedures and run operating rooms more efficiently through data-driven tools and ongoing support.

Company Size

1,001-5,000

Company Stage

Early VC

Total Funding

$7.3M

Headquarters

Munich, Germany

Founded

1989

Get referred to Brainlab

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 2026 Amrita Hospital partnership expands Brainlab's North India neuro-spine footprint.
  • May 2026 CE marking for Elements Spine Planning broadens EU clinical adoption immediately.
  • September 2026 Advanced Motion Management strengthens lung-radiotherapy positioning against motion-management rivals.

What critics are saying

  • Brainlab canceled its Frankfurt IPO in July 2025, limiting cheaper expansion capital.
  • Medtronic's Stealth AXiS and J&J's VELYS Spine attack Brainlab's spine-navigation margin pool.
  • Loop-X and mixed-reality systems need hospital capex; procurement freezes can stall installations quickly.

What makes Brainlab unique

  • Brainlab sells integrated navigation, imaging, and planning across 4,000 hospitals in 120 countries.
  • Loop-X brings intraoperative 2D/3D imaging into surgery, reducing outside-OR workflow interruptions.
  • Elements Spine Planning and Mixed Reality Navigation fuse AI, navigation, and surgeon-visible guidance.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Paid Vacation

Paid Holidays

Conference Attendance Budget

Professional Development Budget

Wellness Program

Mental Health Support

Stock Options

Company Equity

401(k) Retirement Plan

401(k) Company Match

Phone/Internet Stipend

Home Office Stipend

Health Insurance

Growth & Insights and Company News

Headcount

6 month growth

↓ -1%

1 year growth

↓ -1%

2 year growth

↑ 0%
Drug Today Group of Publications
Sep 21st, 2026
Brainlab and Amrita Hospital, Faridabad Sign MoU to Establish North India's First Brain & Spine Centre of Excellence

Brainlab and Amrita Hospital, Faridabad sign MoU to establish North India's first Brain & Spine Centre of Excellence. Discover more Health A-Z Guide Medical Facilities & Services * By Rohit Shishodia * September 21, 2026 * City Patients needing complex brain and spine surgery in North India may soon have access to more advanced technology closer to home. Brainlab and Amrita Hospital, Faridabad have signed an MoU to establish North India's first Centre of Excellence for Brain & Spine, powered by Brainlab's Loop-X Mobile Imaging Robot. The new centre will bring together the medical expertise of Amrita Hospital with Brainlab's advanced imaging and surgical navigation technology. It will focus on complex brain and spine surgeries and will also serve as a centre for clinical training, technology demonstrations and knowledge sharing among surgeons and other healthcare professionals. At the heart of the centre will be Loop-X, a robotic mobile imaging system that can produce detailed 2D and 3D images inside the operating room. This means surgeons can see updated images during an operation, use them with surgical navigation and check the results before the patient leaves the operating room. This can be particularly useful during complicated brain and spine procedures, where even small differences in the position of an implant or the anatomy can matter. The system allows surgeons to take fresh images during surgery, check implant placement and get a clearer view of the area being treated. Its patient-specific imaging can also focus the scan on the required area, helping optimise radiation exposure. Loop-X combines robotic movement with 2D and 3D intraoperative imaging. Its large opening allows patients to be positioned in different ways, while the robotic design allows images to be taken again during surgery when clinically required. The system can also combine these images with Brainlab's navigation technology, giving the surgical team current information without having to interrupt the operation for imaging outside the operating room. Aseem Malhotra, Managing Director, Brainlab India, said the partnership would help bring advanced imaging and navigation technology closer to routine clinical practice in neuro and spine care. He said the technology would support connected surgical workflows, patient-specific imaging and accuracy checks during surgery. Dr Sanjeev Singh, Medical Director, Amrita Hospital, Faridabad, said the centre would strengthen the hospital's capabilities for patients requiring complex neuro and spine care. According to him, advanced imaging and navigation can give clinical teams better visibility during surgery and allow them to verify the results inside the operating room itself. The proposed Centre of Excellence is also expected to become a hub for advanced brain and spine surgery, clinical learning and technology-led surgical innovation. Through the partnership, Brainlab and Amrita Hospital aim to expand access to specialised neuro and spine care for patients across North India. Discover more Medical information resource Drug Information Database Healthcare

MarketScreener
May 25th, 2026
Nexstim raises $4.3M from Eiffel and Brainlab, registers 840,000 new shares

Finnish medical technology company Nexstim has registered 502,500 new shares with the Finnish Trade Register following investments from Eiffel Investment Group and Brainlab SE. Eiffel invested €3.4 million for 446,459 shares, whilst Brainlab invested €0.4 million for 56,041 shares. Additionally, Eiffel exercised 263,091 option rights and other option holders exercised 74,372 option rights, resulting in 337,463 new shares being registered. The new shares began trading on Nasdaq First North Growth Market Finland alongside existing shares. Following the registrations, Nexstim's total share count stands at 8,074,859. The company develops navigated transcranial magnetic stimulation technology for brain diagnostics and therapy, with FDA-cleared systems for pre-surgical brain mapping and treating major depressive disorder.

MarketScreener
May 25th, 2026
Nexstim registers $4.3M investment from Eiffel and Brainlab, issues 840K new shares

Finnish medical technology company Nexstim has registered 840,000 new shares with the Finnish Trade Register following recent investments and option exercises. The company issued 502,500 shares to Eiffel Investment Group (€3.4 million) and Brainlab SE (€0.4 million), registered on 18 May and trading from 20 May. Additionally, 337,463 shares were issued through option exercises, including 263,091 by Eiffel and 74,372 by existing option holders, registered on 22 May and trading from 25 May. Following these registrations, Nexstim's total share count stands at 8,074,859. The company develops navigated transcranial magnetic stimulation technology for brain diagnostics and therapy, with its NBS System 6 FDA-cleared for pre-surgical brain mapping and treating major depressive disorder and obsessive compulsive disorder.

FinanzNachrichten.de
May 14th, 2026
Nexstim Oyj: Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain Option Holders

Company Announcement, Helsinki, 13 May 2026 at 09:05 AM (EEST) Inside Information: Nexstim Plc Announces EUR 5 Million Investment from Eiffel and from Brainlab and Conversion of Options by Certain Option

AD HOC NEWS
May 13th, 2026
AB S.A. secures $5.6M investment from Eiffel and Brainlab to boost healthcare IT expansion

AB S.A., a Polish healthcare technology company, has secured €5 million in investment from Eiffel Investment Group and Brainlab. The funding coincides with option conversions by certain holders, strengthening the company's financial position. AB S.A. operates in the healthcare technology sector, providing software solutions including electronic health records, practice management systems and telehealth platforms for medical practices and laboratories. The company generates revenue through subscription-based software and services, primarily serving markets across Poland and Europe. The investment signals investor confidence in AB S.A.'s growth prospects within the European healthcare IT sector. The capital will support product development and market expansion efforts as the company benefits from ongoing digitalisation trends in European healthcare.